ID
37939
Beschreibung
Study ID: 104864/627 Clinical Study ID: 104864/627 Study Title: An Open-label, Multicenter, Non-Comparative Phase II Study of the Combination of Intravenous Topotecan and Gemcitabine Administered Once Weekly for Three Weeks Every 28 Days as Second-line Treatment in Patients With Recurrent Platinum Sensitive Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00061308 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan, Gemcitabine Study Indication: Peritoneal Cancer, Ovarian Cancer, Neoplasms, Ovarian, Fallopian Tube Cancer
Stichworte
Versionen (1)
- 01.09.19 01.09.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
1. September 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Intravenous Topotecan and Gemcitabine as Second-line Treatment in Patients With Ovarian Cancer NCT00061308
Course 3 Prior to next Course (Day 25 - 28) - Review of Disease Status; Therapeutic Interventions; End of Course Eligibility; Unscheduled Laboratory Tests; Therapeutic Interventions Log
Beschreibung
Review of Disease Status
Alias
- UMLS CUI-1
- C0699749
- UMLS CUI-2
- C0699752
Beschreibung
Date of Assessment
Datentyp
date
Alias
- UMLS CUI [1]
- C2985720
Beschreibung
Assessment not done
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0220825
- UMLS CUI [1,2]
- C1272696
Beschreibung
Mark only one
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0220825
- UMLS CUI [1,2]
- C2826287
Beschreibung
Date of Progression
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0242656
- UMLS CUI [1,2]
- C0011008
Beschreibung
Mark one
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0221198
- UMLS CUI [1,2]
- C1516048
- UMLS CUI [2]
- C4534461
Beschreibung
Therapeutic Interventions
Alias
- UMLS CUI-1
- C0808232
Beschreibung
End of Course Eligibility
Alias
- UMLS CUI-1
- C0013893
- UMLS CUI-2
- C0750729
- UMLS CUI-3
- C0444930
Beschreibung
Hemoglobin >= 9.0 g/dL [90 g/L] Neutrophils >= 1000 cells/mm3 [>= 1.0 x 10*9 /L] Platelets >= 100,000/mm3 [>= 100.0 x 10*9 /L] No clinically significant non-hematologic drug related toxicity If "Yes“, proceed to next course. If "No”, complete Unscheduled Laboratory Tests.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0013893
Beschreibung
Unscheduled Laboratory Tests - Hematology
Alias
- UMLS CUI-1
- C0022885
- UMLS CUI-2
- C3854240
- UMLS CUI-3
- C0474523
Beschreibung
Unscheduled Laboratory Tests - Hematology
Alias
- UMLS CUI-1
- C0022885
- UMLS CUI-2
- C3854240
- UMLS CUI-3
- C0474523
Beschreibung
Hematology Test
Datentyp
integer
Alias
- UMLS CUI [1]
- C0018941
Beschreibung
Hematology - No Result
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0018941
- UMLS CUI [1,2]
- C1274040
Beschreibung
Hematology - Value
Datentyp
text
Alias
- UMLS CUI [1]
- C0474523
Beschreibung
Hematology - Value out of range and NOT clinically significant
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0474523
- UMLS CUI [1,2]
- C0438215
- UMLS CUI [1,3]
- C2826293
Beschreibung
Hematology - Value out of range and clinically significant
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0474523
- UMLS CUI [1,2]
- C0438215
- UMLS CUI [1,3]
- C2826293
Beschreibung
Therapeutic Interventions
Alias
- UMLS CUI-1
- C0808232
Beschreibung
Line Number
Datentyp
integer
Alias
- UMLS CUI [1]
- C0449788
Beschreibung
Procedure
Datentyp
text
Alias
- UMLS CUI [1]
- C2700391
Beschreibung
Procedure details
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2700391
- UMLS CUI [1,2]
- C1522508
Beschreibung
Procedure Time
Datentyp
time
Alias
- UMLS CUI [1,1]
- C2700391
- UMLS CUI [1,2]
- C0040223
Beschreibung
Procedure Date
Datentyp
date
Alias
- UMLS CUI [1,1]
- C2700391
- UMLS CUI [1,2]
- C0011008
Ähnliche Modelle
Course 3 Prior to next Course (Day 25 - 28) - Review of Disease Status; Therapeutic Interventions; End of Course Eligibility; Unscheduled Laboratory Tests; Therapeutic Interventions Log
C0600091 (UMLS CUI [1,2])
C0699752 (UMLS CUI-2)
C1272696 (UMLS CUI [1,2])
C2826287 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C1516048 (UMLS CUI [1,2])
C4534461 (UMLS CUI [2])
C0013221 (UMLS CUI [2,1])
C0304229 (UMLS CUI [2,2])
C0750729 (UMLS CUI-2)
C0444930 (UMLS CUI-3)
C3854240 (UMLS CUI-2)
C0474523 (UMLS CUI-3)
C1302413 (UMLS CUI [1,2])
C3258037 (UMLS CUI [1,2])
C3854240 (UMLS CUI-2)
C0474523 (UMLS CUI-3)
C1274040 (UMLS CUI [1,2])
C0438215 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
C0438215 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
C1522508 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
Keine Kommentare